Rowan K M, Kerr J H, Major E, McPherson K, Short A, Vessey M P
Department of Public Health and Primary Care, University of Oxford, Radcliffe Infirmary.
BMJ. 1993 Oct 16;307(6910):977-81. doi: 10.1136/bmj.307.6910.977.
To compare outcome between intensive care units in Britain and Ireland both before and after adjustment for case mix with the American APACHE II method and to validate the American APACHE II method in Britain and Ireland.
Prospective, cohort study of consecutive admissions to intensive care units.
26 general intensive care units in Britain and Ireland.
8796 admissions to the study intensive care units.
Death or survival at discharge from intensive care unit and hospital.
At discharge from both intensive care unit and hospital there was a greater than twofold variation in crude mortality between the 26 units. After adjustment for case mix, variations in mortality were still apparent. For four intensive care units the observed numbers of deaths were significantly different from the number predicted by the American APACHE II equation. The overall goodness of fit, or predictive ability, of the APACHE II equation for the British and Irish data was good, being only slightly inferior to that obtained when the equation was tested on the data from which it had been derived. When patients were grouped by various factors such as age and diagnosis, the equation did not adjust across the subgroups in a uniform manner.
The American APACHE II equation did not fit the British and Irish data. Use of the American equation could be of advantage or disadvantage to individual intensive care units, depending on the mix of patients treated.
运用美国急性生理学及慢性健康状况评分系统Ⅱ(APACHE II)方法,比较英国和爱尔兰重症监护病房在病例组合调整前后的结局,并在英国和爱尔兰验证美国APACHE II方法。
对重症监护病房连续收治患者进行前瞻性队列研究。
英国和爱尔兰的26个普通重症监护病房。
8796例入住研究重症监护病房的患者。
重症监护病房及医院出院时的死亡或存活情况。
在重症监护病房及医院出院时,26个病房的粗死亡率存在两倍以上的差异。经病例组合调整后,死亡率差异仍然明显。对于4个重症监护病房,观察到的死亡人数与美国APACHE II方程预测的人数显著不同。APACHE II方程对英国和爱尔兰数据的整体拟合优度或预测能力良好,仅略逊于在其推导数据上进行测试时获得的结果。当按年龄和诊断等各种因素对患者进行分组时,该方程在各亚组中的调整并不一致。
美国APACHE II方程不适用于英国和爱尔兰的数据。使用美国方程对各个重症监护病房可能有利也可能有弊,这取决于所治疗患者的组合情况。